AZTA Stock Forecast 2025-2026
Distance to AZTA Price Targets
AZTA Price Momentum
🤔 Considering Azenta (AZTA)?
Join 5,000+ investors getting our exclusive market analysis every Monday & Thursday. Stay ahead of breakout opportunities.
Latest AZTA Stock Price Targets & Analyst Predictions
Based on our analysis of 7 Wall Street analysts, AZTA has a neutral consensus with a median price target of $52.00 (ranging from $50.00 to $79.00). The overall analyst rating is Buy (6.9/10). Currently trading at $36.80, the median forecast implies a 41.3% upside. This outlook is supported by 2 Buy, 5 Hold, and 0 Sell ratings.
The most optimistic forecast comes from Yuan Zhi at B. Riley Securities, projecting a 114.7% upside. Conversely, the most conservative target is provided by Vijay Kumar at Evercore ISI Group, suggesting a 35.9% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
AZTA Analyst Ratings
AZTA Price Target Range
Latest AZTA Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for AZTA.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Feb 6, 2025 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $52.00 |
| Feb 6, 2025 | Needham | David Saxon | Buy | Maintains | $59.00 |
| Jan 2, 2025 | Stephens & Co. | Jacob Johnson | Overweight | Reiterates | $60.00 |
| Dec 18, 2024 | Stephens & Co. | Overweight | Upgrade | $0.00 | |
| Nov 13, 2024 | Needham | David Saxon | Buy | Maintains | $55.00 |
| Oct 1, 2024 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $50.00 |
| Aug 7, 2024 | Needham | David Saxon | Buy | Reiterates | $69.00 |
| Jul 2, 2024 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $53.00 |
| May 9, 2024 | Needham | David Saxon | Buy | Maintains | $69.00 |
| Apr 8, 2024 | Needham | David Saxon | Buy | Maintains | $75.00 |
| Apr 4, 2024 | Evercore ISI Group | Vijay Kumar | In-Line | Maintains | $60.00 |
| Apr 4, 2024 | Jefferies | Matthew Stanton | Hold | Initiates | $64.00 |
| Mar 28, 2024 | Needham | David Saxon | Buy | Reiterates | $75.00 |
| Mar 14, 2024 | Needham | David Saxon | Buy | Maintains | $75.00 |
| Mar 7, 2024 | Needham | David Saxon | Buy | Reiterates | $75.00 |
| Feb 8, 2024 | Needham | David Saxon | Buy | Maintains | $75.00 |
| Feb 8, 2024 | Stephens & Co. | Jacob Johnson | Equal-Weight | Reiterates | $70.00 |
| Feb 1, 2024 | B. Riley Securities | Yuan Zhi | Buy | Maintains | $79.00 |
| Jan 18, 2024 | Needham | David Saxon | Buy | Maintains | $76.00 |
| Nov 14, 2023 | Needham | David Saxon | Buy | Reiterates | $68.00 |
Azenta Inc. (AZTA) Competitors
The following stocks are similar to Azenta based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Azenta Inc. (AZTA) Financial Data
Azenta Inc. has a market capitalization of $1.68B with a P/E ratio of -11.9x. The company generates $662.11M in trailing twelve-month revenue with a -24.4% profit margin.
Revenue growth is +4.1% quarter-over-quarter, while maintaining an operating margin of -7.4% and return on equity of -8.0%.
Valuation Metrics
Growth & Margins
Financial Health
🔥 Want More High-Potential Stock Ideas?
Join 5,000+ investors getting our research on stocks with massive upside potential.
Azenta Inc. (AZTA) Business Model
About Azenta Inc.
Provides sample management solutions for life sciences.
Azenta Inc. generates revenue by offering sample management and storage solutions to pharmaceutical and biotech companies. Their services include advanced automation systems that streamline the management of biological samples, thereby enhancing research and development efficiency.
The company operates in several sectors within the life sciences industry, including biobanking, genomic testing, and cell therapy applications. By meeting the demand for efficient sample storage and data management, Azenta Inc. plays a vital role in advancing healthcare through improved sample integrity and compliance with regulatory standards.
Company Information
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
3,000
CEO
Mr. John P. Marotta
Country
United States
IPO Year
2011
Website
www.azenta.comAzenta Inc. (AZTA) Latest News & Analysis
Azenta, Inc. (Nasdaq: AZTA) announced leadership changes on March 10, 2025, with details regarding Lawrence Y. not specified in the excerpt.
Leadership changes can impact company strategy and performance, influencing stock prices and investor sentiment towards Azenta, Inc. (AZTA).
Investors should monitor Azenta (AZTA) stock due to recent activity in the options market.
Increased activity in Azenta's options market may signal anticipated volatility or shifts in investor sentiment, potentially impacting the stock's price movements.
Azenta, Inc. (NASDAQ: AZTA) will host its Q1 2025 Earnings Conference Call on February 5, 2025, at 8:30 AM ET, featuring key executives and analysts from various firms.
The upcoming Q1 2025 earnings call for Azenta, Inc. will provide insights into financial performance and strategic direction, crucial for assessing investment potential and market confidence.
Azenta, Inc. (Nasdaq: AZTA) released its financial results for Q1 ended December 31, 2024, on February 5, 2025. Further details on performance will be available in the report.
Azenta's Q1 financial results can impact its stock performance, influencing investor sentiment and potential future valuations based on revenue growth and profitability.
Azenta, Inc. announced the election of Dipal Doshi, CEO of Entrada Therapeutics, to its Board of Directors during its Annual Meeting on January 30, 2025.
Dipal Doshi's election to Azenta's Board could enhance strategic direction and industry expertise, potentially boosting investor confidence and impacting stock performance.
Azenta, Inc. (Nasdaq: AZTA) will release its fiscal Q1 2025 earnings report on February 5, 2025, prior to market opening.
Azenta's upcoming earnings announcement could impact its stock price, reflecting financial health and performance, influencing investor sentiment and market trends.
Frequently Asked Questions About AZTA Stock
What is Azenta Inc.'s (AZTA) stock forecast for 2025?
Based on our analysis of 7 Wall Street analysts, Azenta Inc. (AZTA) has a median price target of $52.00. The highest price target is $79.00 and the lowest is $50.00.
Is AZTA stock a good investment in 2025?
According to current analyst ratings, AZTA has 2 Buy ratings, 5 Hold ratings, and 0 Sell ratings. The stock is currently trading at $36.80. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for AZTA stock?
Wall Street analysts predict AZTA stock could reach $52.00 in the next 12 months. This represents a 41.3% increase from the current price of $36.80. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Azenta Inc.'s business model?
Azenta Inc. generates revenue by offering sample management and storage solutions to pharmaceutical and biotech companies. Their services include advanced automation systems that streamline the management of biological samples, thereby enhancing research and development efficiency.
What is the highest forecasted price for AZTA Azenta Inc.?
The highest price target for AZTA is $79.00 from Yuan Zhi at B. Riley Securities, which represents a 114.7% increase from the current price of $36.80.
What is the lowest forecasted price for AZTA Azenta Inc.?
The lowest price target for AZTA is $50.00 from Vijay Kumar at Evercore ISI Group, which represents a 35.9% increase from the current price of $36.80.
What is the overall AZTA consensus from analysts for Azenta Inc.?
The overall analyst consensus for AZTA is neutral. Out of 7 Wall Street analysts, 2 rate it as Buy, 5 as Hold, and 0 as Sell, with a median price target of $52.00.
How accurate are AZTA stock price projections?
Stock price projections, including those for Azenta Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
